MedTrace Logo

Study of NMB Drug Ejecting Balloon for Arteriovenous Fistulae

NCT01646788 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2012-07-24

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the safety and effectiveness of the use of NMB's percutaneous transluminal angioplasty (PTA) for the treatment of obstructive lesions of Arteriovenous (AV) Dialysis Fistulae/Grafts.

Conditions

  • Obstructive Lesions of Arteriovenous Dialysis Fistulae

Interventions

DEVICE

NMB Paclitaxel Drug Ejecting Balloon

NMB's PTA Balloon catheter with drug

Sponsors & Collaborators

  • N.M.B. Medical Applications Ltd

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-01-31
Completion
2015-01-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01646788 on ClinicalTrials.gov